miR-22 Controls Irf8 mRNA Abundance and Murine Dendritic Cell Development

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Li, Haiyan S ^a   Greeley, Nathaniel ^a,c   Sugimoto, Naoshi ^b   Liu, Yong Jun ^a,b   Watowich, Stephanie S ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MESSENGER RNA; MICRORNA 22;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; IRF8 GENE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD45; CELL DIFFERENTIATION; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON REGULATORY FACTORS; MICE; MICE, INBRED C57BL; MICRORNAS; RNA, MESSENGER;

MURINAE;

EID: 84871262291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052341     Document Type: Article

References (66)

1. Berezikov E, (2011) Evolution of microRNA diversity and regulation in animals. Nature reviews Genetics 12: 846-860.
2. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
3. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, et al. (2002) miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes & development 16: 720-728.
4. Dai R, Ahmed SA, (2011) MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Translational research: the journal of laboratory and clinical medicine 157: 163-179.
5. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, et al. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Molecular cell 15: 185-197.
6. Hutvagner G, Simard MJ, (2008) Argonaute proteins: key players in RNA silencing. Nature reviews Molecular cell biology 9: 22-32.
7. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, (2008) MicroRNAs: new regulators of immune cell development and function. Nature immunology 9: 839-845.
8. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, et al. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
9. Neilson JR, Zheng GX, Burge CB, Sharp PA, (2007) Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes & development 21: 578-589.
10. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020.
11. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859.
12. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
13. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
14. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, et al. (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
15. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, et al. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831.
16. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, et al. (2007) An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
17. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
18. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, et al. (2005) Aberrant T cell differentiation in the absence of Dicer. The Journal of experimental medicine 202: 261-269.
19. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. (2005) Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes & development 19: 489-501.
20. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, et al. (2006) A role for Dicer in immune regulation. The Journal of experimental medicine 203: 2519-2527.
21. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY, (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. The Journal of experimental medicine 205: 1993-2004.
22. Zhou L, Seo KH, He HZ, Pacholczyk R, Meng DM, et al. (2009) Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proceedings of the National Academy of Sciences of the United States of America 106: 10266-10271.
23. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, et al. (2008) Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874.
24. Watowich SS, Liu YJ, (2010) Mechanisms regulating dendritic cell specification and development. Immunol Rev 238: 76-92.
25. Li HS, Watowich SS, (2012) A STATus report on DC development. J Leukoc Biol 92: 445-459.
26. Li HS, Yang CY, Nallaparaju KC, Zhang H, Liu YJ, et al. (2012) The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. Blood: (in press).
27. Pandey DP, Picard D, (2009) miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29: 3783-3790.
28. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, et al. (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193: 409-424.
29. Naik SH, O'Keeffe M, Proietto A, Shortman HH, Wu L, (2010) CD8+, CD8-, and plasmacytoid dendritic cell generation in vitro using flt3 ligand. Methods Mol Biol 595: 167-176.
30. Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, et al. (2005) Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174: 6592-6597.
31. Esashi E, Wang YH, Perng O, Qin XF, Liu YJ, et al. (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28: 509-520.
32. Mishima T, Mizuguchi Y, Kawahigashi Y, Takizawa T, Takizawa T, (2007) RT-PCR-based analysis of microRNA (miR-1 and-124) expression in mouse CNS. Brain Res 1131: 37-43.
33. Li HS, Gelbard A, Martinez GJ, Esashi E, Zhang H, et al. (2011) Cell-intrinsic role for IFN-alpha-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 118: 3879-3889.
34. Paglia P, Girolomoni G, Robbiati F, Granucci F, Ricciardi-Castagnoli P, (1993) Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med 178: 1893-1901.
35. Aliberti J, Schulz O, Pennington DJ, Tsujimura H, Reis e Sousa C, et al. (2003) Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 101: 305-310.
36. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, et al. (2011) IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 365: 127-138.
37. Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, et al. (2004) ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103: 2221-2228.
38. Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, et al. (2002) ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 196: 1415-1425.
39. Tailor P, Tamura T, Morse HC 3rd, Ozato K (2008) The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 111: 1942-1945.
40. Tsujimura H, Tamura T, Ozato K, (2003) Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 170: 1131-1135.
41. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, et al. (2010) CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107: 14745-14750.
42. Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, et al. (2010) Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med 207: 823-836.
43. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, et al. (2008) Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
44. Carissimi C, Fulci V, Macino G, (2009) MicroRNAs: novel regulators of immunity. Autoimmunity reviews 8: 520-524.
45. Belver L, Papavasiliou FN, Ramiro AR, (2011) MicroRNA control of lymphocyte differentiation and function. Current opinion in immunology 23: 368-373.
46. Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, et al. (2009) The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 206: 3115-3130.
47. Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, et al. (2005) IFN regulatory factor-4 and-8 govern dendritic cell subset development and their functional diversity. J Immunol 174: 2573-2581.
48. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
49. Li X, Liu J, Zhou R, Huang S, Chen XM, (2010) Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. British journal of haematology 148: 69-79.
50. Huang S, Wang S, Bian C, Yang Z, Zhou H, et al. (2012) Upregulation of miR-22 Promotes Osteogenic Differentiation and Inhibits Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells by Repressing HDAC6 Protein Expression. Stem Cells Dev 21: 2531-2540.
51. Xiong J, Du Q, Liang Z, (2010) Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29: 4980-4988.
52. Li J, Liang S, Jin H, Xu C, Ma D, et al. (2012) Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncology reports 27: 1835-1842.
53. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, et al. (2011) miR-22 represses cancer progression by inducing cellular senescence. The Journal of cell biology 193: 409-424.
54. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, et al. (2011) Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer research 71: 4628-4639.
55. Takata A, Otsuka M, Kojima K, Yoshikawa T, Kishikawa T, et al. (2011) MicroRNA-22 and microRNA-140 suppress NF-kappaB activity by regulating the expression of NF-kappaB coactivators. Biochemical and biophysical research communications 411: 826-831.
56. Bar N, Dikstein R, (2010) miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 5: e10859.
57. Tan G, Shi Y, Wu ZH, (2012) MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. Biochemical and biophysical research communications 417: 546-551.
58. Pandey DP, Picard D, (2009) miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Molecular and cellular biology 29: 3783-3790.
59. Sathaliyawala T, O'Gorman WE, Greter M, Bogunovic M, Konjufca V, et al. (2010) Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33: 597-606.
60. Zanoni I, Granucci F, (2010) Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors. Journal of molecular medicine 88: 873-880.
61. Seillet C, Laffont S, Tremollieres F, Rouquie N, Ribot C, et al. (2012) The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling. Blood 119: 454-464.
62. Kuipers H, Schnorfeil FM, Brocker T, (2010) Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell development. Mol Immunol 48: 333-340.
63. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, et al. (2009) MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114: 404-414.
64. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37-48.
65. Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B, (2010) Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33: 905-916.
66. Nagasawa M, Schmidlin H, Hazekamp MG, Schotte R, Blom B, (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur J Immunol 38: 2389-2400.